← All trials
NCT04156243
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2018
- Primary completion
- Feb 28, 2020
- Completion date
- Feb 28, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- iCell Gene TherapeuticsLead sponsor
- iCell Gene TherapeuticsCollaborator
- Peking UniversityCollaborator
- Peking UniversityOverall official - principal investigator
- People's Liberation Army of ChinaOverall official - principal investigator
- People's Liberation Army of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.